NO20082497L - Diarylureaer for behandling av pulmonal hypertensjon - Google Patents
Diarylureaer for behandling av pulmonal hypertensjonInfo
- Publication number
- NO20082497L NO20082497L NO20082497A NO20082497A NO20082497L NO 20082497 L NO20082497 L NO 20082497L NO 20082497 A NO20082497 A NO 20082497A NO 20082497 A NO20082497 A NO 20082497A NO 20082497 L NO20082497 L NO 20082497L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- pulmonary hypertension
- diarylureas
- diarylurea compound
- diarylurea
- Prior art date
Links
- 208000002815 pulmonary hypertension Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229960003787 sorafenib Drugs 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05024508 | 2005-11-10 | ||
| EP05027449 | 2005-12-15 | ||
| EP06007775 | 2006-04-13 | ||
| PCT/EP2006/010405 WO2007054215A1 (en) | 2005-11-10 | 2006-10-30 | Diaryl ureas for treating pulmonary hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082497L true NO20082497L (no) | 2008-06-03 |
Family
ID=37651281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082497A NO20082497L (no) | 2005-11-10 | 2008-06-03 | Diarylureaer for behandling av pulmonal hypertensjon |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20090176791A1 (da) |
| EP (1) | EP1948176B1 (da) |
| JP (1) | JP5075832B2 (da) |
| KR (1) | KR20080066030A (da) |
| AR (1) | AR057848A1 (da) |
| AT (1) | ATE493986T1 (da) |
| AU (1) | AU2006312713A1 (da) |
| BR (1) | BRPI0618524A2 (da) |
| CA (1) | CA2628847A1 (da) |
| CU (1) | CU23815A3 (da) |
| DE (1) | DE602006019468D1 (da) |
| DK (1) | DK1948176T3 (da) |
| EC (1) | ECSP088429A (da) |
| IL (1) | IL191010A0 (da) |
| MY (1) | MY144860A (da) |
| NO (1) | NO20082497L (da) |
| NZ (1) | NZ568031A (da) |
| PL (1) | PL1948176T3 (da) |
| PT (1) | PT1948176E (da) |
| SV (1) | SV2009002899A (da) |
| TW (1) | TW200735869A (da) |
| UY (1) | UY29902A1 (da) |
| WO (1) | WO2007054215A1 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| EP2298311B1 (en) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| DK1478358T3 (da) | 2002-02-11 | 2013-10-07 | Bayer Healthcare Llc | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese |
| UY28213A1 (es) | 2003-02-28 | 2004-09-30 | Bayer Pharmaceuticals Corp | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. |
| EP1636585B2 (en) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
| PL1663978T3 (pl) | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
| DE602006017188D1 (de) | 2005-03-07 | 2010-11-11 | Bayer Schering Pharma Ag | Pharmazeutische zusammensetzung mit einem omega-carboxyaryl-substituierten diphenylharnstoff zur behandlung von krebs |
| WO2007087575A2 (en) * | 2006-01-24 | 2007-08-02 | University Of Chicago | Compositions and methods for treating pulmonary hypertension |
| AR062927A1 (es) * | 2006-10-11 | 2008-12-17 | Bayer Healthcare Ag | 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada |
| ES2429107T3 (es) | 2007-01-19 | 2013-11-13 | Bayer Healthcare Llc | Tratamiento de cánceres con una resistencia adquirida a los agentes inhibidores de KIT |
| WO2009156070A1 (en) * | 2008-06-25 | 2009-12-30 | Bayer Schering Pharma Aktiengesellschaft | Diaryl urea for treating heart failure |
| JP2013538840A (ja) | 2010-10-01 | 2013-10-17 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 置換ｎ−（２−アリールアミノ）アリールスルホンアミドを含有する組み合わせ |
| EP2723718A1 (en) | 2011-06-24 | 2014-04-30 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| AP2013007331A0 (en) | 2011-06-24 | 2013-12-31 | Amgen Inc | TRPM8 antagonists and their use in treatments |
| US8586527B2 (en) * | 2011-10-20 | 2013-11-19 | Jaipal Singh | Cerivastatin to treat pulmonary disorders |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| WO2014110200A1 (en) | 2013-01-10 | 2014-07-17 | Zisman Lawrence S | Non-selective kinase inhibitors |
| ES2959419T3 (es) | 2013-10-11 | 2024-02-26 | Pulmokine Inc | Formulaciones secas por aspersión |
| WO2015089105A1 (en) | 2013-12-09 | 2015-06-18 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
| US11057446B2 (en) | 2015-05-14 | 2021-07-06 | Bright Data Ltd. | System and method for streaming content from multiple servers |
| RU2763525C2 (ru) | 2016-10-27 | 2021-12-30 | Пульмокин, Инк. | Комбинированная терапия для лечения легочной гипертензии |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020065296A1 (en) * | 1999-01-13 | 2002-05-30 | Bayer Corporation | Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| US7928239B2 (en) * | 1999-01-13 | 2011-04-19 | Bayer Healthcare Llc | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| DK1478358T3 (da) * | 2002-02-11 | 2013-10-07 | Bayer Healthcare Llc | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese |
| EP1636585B2 (en) * | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
-
2006
- 2006-10-30 CA CA002628847A patent/CA2628847A1/en not_active Abandoned
- 2006-10-30 AT AT06828882T patent/ATE493986T1/de active
- 2006-10-30 MY MYPI20081362A patent/MY144860A/en unknown
- 2006-10-30 BR BRPI0618524-0A patent/BRPI0618524A2/pt not_active IP Right Cessation
- 2006-10-30 DK DK06828882.8T patent/DK1948176T3/da active
- 2006-10-30 PT PT06828882T patent/PT1948176E/pt unknown
- 2006-10-30 AU AU2006312713A patent/AU2006312713A1/en not_active Abandoned
- 2006-10-30 PL PL06828882T patent/PL1948176T3/pl unknown
- 2006-10-30 KR KR1020087011176A patent/KR20080066030A/ko not_active Ceased
- 2006-10-30 DE DE602006019468T patent/DE602006019468D1/de active Active
- 2006-10-30 US US12/084,659 patent/US20090176791A1/en not_active Abandoned
- 2006-10-30 JP JP2008539298A patent/JP5075832B2/ja not_active Expired - Fee Related
- 2006-10-30 NZ NZ568031A patent/NZ568031A/en not_active IP Right Cessation
- 2006-10-30 WO PCT/EP2006/010405 patent/WO2007054215A1/en not_active Ceased
- 2006-10-30 EP EP06828882A patent/EP1948176B1/en not_active Not-in-force
- 2006-10-31 AR ARP060104766A patent/AR057848A1/es not_active Application Discontinuation
- 2006-11-07 UY UY29902A patent/UY29902A1/es unknown
- 2006-11-09 TW TW095141430A patent/TW200735869A/zh unknown
-
2008
- 2008-04-27 IL IL191010A patent/IL191010A0/en unknown
- 2008-05-06 EC EC2008008429A patent/ECSP088429A/es unknown
- 2008-05-06 SV SV2008002899A patent/SV2009002899A/es unknown
- 2008-05-08 CU CU20080082A patent/CU23815A3/es not_active IP Right Cessation
- 2008-06-03 NO NO20082497A patent/NO20082497L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ568031A (en) | 2011-06-30 |
| CA2628847A1 (en) | 2007-05-18 |
| ECSP088429A (es) | 2008-07-30 |
| AR057848A1 (es) | 2007-12-19 |
| CU20080082A7 (es) | 2011-07-11 |
| CU23815A3 (es) | 2012-06-21 |
| IL191010A0 (en) | 2009-08-03 |
| JP2009514909A (ja) | 2009-04-09 |
| ATE493986T1 (de) | 2011-01-15 |
| US20090176791A1 (en) | 2009-07-09 |
| DE602006019468D1 (de) | 2011-02-17 |
| EP1948176A1 (en) | 2008-07-30 |
| TW200735869A (en) | 2007-10-01 |
| UY29902A1 (es) | 2007-06-29 |
| KR20080066030A (ko) | 2008-07-15 |
| JP5075832B2 (ja) | 2012-11-21 |
| SV2009002899A (es) | 2009-04-28 |
| PL1948176T3 (pl) | 2011-05-31 |
| DK1948176T3 (da) | 2011-04-18 |
| MY144860A (en) | 2011-11-30 |
| WO2007054215A1 (en) | 2007-05-18 |
| BRPI0618524A2 (pt) | 2011-09-06 |
| EP1948176B1 (en) | 2011-01-05 |
| AU2006312713A1 (en) | 2007-05-18 |
| PT1948176E (pt) | 2011-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23815A3 (es) | Diarilureas para el tratamiento de hipertensión pulmonar | |
| NO20082090L (no) | Pyridopyrimidinoninhibitorer av P13K alfa | |
| NO20080622L (no) | Disykloalkylurea-glukokinase aktivatorer | |
| WO2008131000A3 (en) | 7-substituted indole mcl-1 inhibitors | |
| NO20052626D0 (no) | Middel for forhindring eller behandling av neuropati | |
| NO20081042L (no) | PPAR aktive forbindelser | |
| WO2006110816A3 (en) | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors | |
| WO2007126957A3 (en) | New compounds | |
| WO2009042114A3 (en) | Phenazine derivatives and uses thereof | |
| DK1984357T3 (da) | 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme | |
| NO20083923L (no) | Pyrazolkinoloner er potente parp-inhibitorer | |
| NO20092711L (no) | Metoder for anvendelse av cyclopaminanaloger | |
| NO20072352L (no) | Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet | |
| CL2008003691A1 (es) | Compuestos derivados de 4-(fenil o piridin) pirimidina, inhibidores de la elastasa neutrofila humana; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o la prevencion de hipertension arterial pulmonar, epoc, enfisema pulmonar, entre otras. | |
| NO20072608L (no) | Biaryloksymetylarenkarboksylsyrer | |
| NO20070855L (no) | Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer. | |
| NO20072963L (no) | 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere | |
| DK2209778T3 (da) | Pyridin-2-yl-amino-1, 2, 4-thiadiazolderivater som glucokinase-aktivatorer til behandling af diabetes mellitus | |
| NO20090764L (no) | 4-hydroksytiobenzamidderivater og legemidler | |
| UY29616A1 (es) | Compuestos químicos iii | |
| UY29615A1 (es) | Compuestos quimicos iv | |
| NO20091353L (no) | Serine hydrolaseinhibitorer | |
| ATE464307T1 (de) | Mif-hemmer | |
| WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
| WO2008048121A3 (en) | Macrocyclic cysteine protease inhibitors and compositions thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |